Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€12.40

€12.40

-0.800%
-0.1
-0.800%
€18.69
 
25.07.25 / Stuttgart Stock Exchange WKN: A2AMY9 / Symbol: PLSE / Name: Pulse / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Pulse Biosciences Inc Stock

The price for the Pulse Biosciences Inc stock decreased slightly today. Compared to yesterday there is a change of -€0.100 (-0.800%).
Currently there is a rather negative sentiment for Pulse Biosciences Inc with 1 Buy predictions and 4 Sell predictions..
On the other hand, the target price of 18 € is above the current price of 12.4 € for Pulse Biosciences Inc, so the potential is actually 45.16%.

Pros and Cons of Pulse Biosciences Inc in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15

Pulse Biosciences (NASDAQ: PLSE) operates within the Healthcare Equipment and Supplies industry, developing and commercializing innovative medical technologies. From a general perspective, the company's financials raise some concerns with negative net income and decreasing revenues over the years. In addition, an increase in total debt and a negative stockholder's equity pose further risks for investors. However, a strong cash position might provide buffer and sustainability to the company in short and medium-term. A thorough assessment of the provided financial statements will provide a better insight into the company's overall financial health.

Strong Cash Position: As of 2022-12-31, the company possesses $61,139,000 in cash, a significant increase from $28,614,000 in 2021-12-31. This robust cash reserve suggests that Pulse has sufficient liquidity to manage operational activities and weather economic uncertainties in the short term.

Decreased Inventory: Pulse's inventory dropped from $5,824,000 in 2021-12-31 to $0 in 2022-12-31, a positive sign for maintaining operational efficiency and reducing storage costs. However, this should be observed alongside revenue changes in order to avoid understocking.

Comments

Prediction Buy
Perf. (%) -6.06%
Target price 18.687
Change
Ends at 07.07.26

Pulse Biosciences, Inc (NASDAQ: PLSE) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $22.00 price target on the stock.
Ratings data for PLSE provided by MarketBeat
Show more

Pulse Biosciences, Inc. (NASDAQ: PLSE) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for PLSE provided by MarketBeat
Show more

Pulse Biosciences, Inc. (NASDAQ: PLSE) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for PLSE provided by MarketBeat
Show more